Loading...
Thumbnail Image
Item

Coping with viral diversity in HIV vaccine design

Nickle, DC
Rolland, M
Jensen, MA
Kosakovsky Pond, SL
Deng, W
Seligman, M
Heckerman, D
Mullins, JI
Jojic, N
Research Projects
Organizational Units
Journal Issue
DOI
10.1371/journal.pcbi.0030075
Abstract
The ability of human immunodeficiency virus type 1 (HIV-1) to develop high levels of genetic diversity, and thereby acquire mutations to escape immune pressures, contributes to the difficulties in producing a vaccine. Possibly no single HIV-1 sequence can induce sufficiently broad immunity to protect against a wide variety of infectious strains, or block mutational escape pathways available to the virus after infection. The authors describe the generation of HIV-1 immunogens that minimizes the phylogenetic distance of viral strains throughout the known viral population (the center of tree [COT]) and then extend the COT immunogen by addition of a composite sequence that includes highfrequency variable sites preserved in their native contexts. The resulting COT+ antigens compress the variation found in many independent HIV-1 isolates into lengths suitable for vaccine immunogens. It is possible to capture 62% of the variation found in the Nef protein and 82% of the variation in the Gag protein into immunogens of three gene lengths. The authors put forward immunogen designs that maximize representation of the diverse antigenic features present in a spectrum of HIV-1 strains. These immunogens should elicit immune responses against high-frequency viral strains as well as against most mutant forms of the virus. © 2007 Nickle et al.
Description
Citation
Citation to related work
Public Library of Science (PLoS)
Has part
PLoS Computational Biology
ADA compliance
For Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.edu
Embedded videos